Subject(s)
COVID-19 , Pandemics , Personnel Staffing and Scheduling/trends , Research Personnel/organization & administration , Research/organization & administration , Teleworking/trends , COVID-19/epidemiology , Education, Distance/trends , Education, Graduate/trends , Humans , Mentoring/trends , Research/education , Research Personnel/education , Surveys and Questionnaires , Videoconferencing/trendsSubject(s)
Black People , Culture , Language , Science , Technology , Africa , Black People/education , Black People/ethnology , Humans , Science/education , Technology/educationSubject(s)
Respiratory Syncytial Virus Infections/mortality , Respiratory Syncytial Virus Infections/prevention & control , Respiratory Syncytial Virus Vaccines/immunology , Respiratory Syncytial Viruses/immunology , Respiratory Syncytial Viruses/pathogenicity , Adult , Aged , Aged, 80 and over , Antibodies, Monoclonal, Humanized/administration & dosage , Antibodies, Monoclonal, Humanized/immunology , Antibodies, Monoclonal, Humanized/therapeutic use , Antibodies, Neutralizing/immunology , Antibodies, Viral/immunology , COVID-19 Vaccines , Child, Preschool , Clinical Trials, Phase III as Topic , Drug Approval , Female , Humans , Immunity, Maternally-Acquired/immunology , Infant , Infant, Newborn , Inflammation/immunology , Pregnancy , Respiratory Syncytial Virus Infections/immunology , Respiratory Syncytial Virus Infections/virology , Respiratory Syncytial Virus Vaccines/adverse effects , Respiratory Syncytial Virus Vaccines/chemistry , Respiratory Syncytial Viruses/chemistry , Viral Fusion Proteins/chemistry , Viral Fusion Proteins/immunology , Viral Fusion Proteins/metabolism , Virus Internalization , mRNA Vaccines/administration & dosage , mRNA Vaccines/immunologySubject(s)
Biomedical Research , COVID-19/epidemiology , COVID-19/virology , Influenza, Human/epidemiology , Research Personnel , SARS-CoV-2/immunology , Antibodies, Neutralizing/pharmacology , Antibodies, Neutralizing/therapeutic use , Antiviral Agents/pharmacology , Australia/epidemiology , Biomedical Research/organization & administration , COVID-19/immunology , COVID-19/therapy , Humans , Immunization, Passive , Induced Pluripotent Stem Cells/cytology , Induced Pluripotent Stem Cells/drug effects , Induced Pluripotent Stem Cells/virology , Influenza, Human/virology , Laboratories/organization & administration , COVID-19 SerotherapySubject(s)
Attitude , Disabled Persons , Leadership , Prejudice/prevention & control , Research Personnel , Research/organization & administration , Disabled Persons/psychology , Efficiency , Female , Humans , Laboratories/organization & administration , Prejudice/statistics & numerical data , Research Personnel/psychology , Social StigmaABSTRACT
[...]scientist-mothers are under-represented at the topmost levels of academia in that nation and elsewhere. [...]many scientist-mothers take on more teaching, service or outreach work to build up their CVs, even though they have fewer hours to spare. Aaron Clauset, a computer scientist at the University of Colorado Boulder, Allison Morgan, then a doctoral student, and their colleagues documented a publication deficit for scientist-mothers in a 2017-18 survey of more than 3,000 tenure-track faculty members from 450 departments at US and Canadian institutions. The Brazilian group also petitioned for a 'maternity clause' to be added to research grant or fellowship applications "to make the competition more fair for mothers", Staniscuaski says. Since 2018, several Brazilian funding agencies have agreed to the clause, which uses either a longer span of years or a correction factor to equalize the assessment of mothers' productivity with that of their non-parent peers.